|
|
|
|
Researchers' work from University of Pennsylvania focuses on dengue fever
- (NewsRx.com) -- 'Dengue virus (DENV) infection is an expanding global threat to public health (see also Dengue Fever).Effective vaccine and treatment approaches remain elusive,' scientists in the United States report. 'B cell...
|
|
|
Aethlon Medical Discloses Initiation of Research Coverage
- Aethlon Medical, Inc.(OTCBB:AEMD) disclosed today that The Robins Group, an independent brokerage and investment banking firm, has initiated research coverage on the Company. The report was prepared and published by The Robins Group...
|
|
|
Aethlon Medical Discloses Initiation of Research Coverage
Aethlon Medical, Inc.(OTCBB:AEMD) disclosed today that The Robins Group, an independent brokerage and investment banking firm, has initiated research coverage on the Company. The report was prepared and published by The Robins Group and...
|
|
|
Child health issues discussed at AKU
By our correspondent Karachi Issues pertaining to the health of children were discussed during a seminar held at the Aga Khan University.Dengue, thalassaemia, malnutrition and iron deficiency along with other diseases affecting...
|
|
|
New U.S. Army Mosquito Control Technology Licensed for DeploymentAgainst Dengue
A novel, patented mosquito-killing technology developed by U.S.Army researchers under a long-term, joint-development agreement between the , the , and the , and targeted at Dengue fever is headed for the field. This technology can...
|
|
|
Dengue Fever - Reports summarize dengue fever research from National Taiwan University
According to a study from Taipei, Taiwan, 'To investigate determinants and evolution linked to with increased severity, we examined dengue type 2 (DENV-2) sequences from plasma of 31 patients (14 dengue fever, 17 dengue hemorrhagic fever,...
|
|
|
Black Barbershop Health Outreach Program Comes To New York City; Offers Free Diabetes Testing For African-Amer
Barbershop Health Outreach Program Comes To New York Offers Free Diabetes Testing For African-American Men isReady mywidth1 (mywidth1 1024 Web Login Password Current Health Popular Topics Photo Gallery Health Releases Archive A-Z Submit...
|
|
|
New Zealand Researchers Question Current Methotrexate Dosage for Rheumatoid Arthritis Treatment
Zealand Researchers Question Current Dosage for Treatment isReady mywidth1 (mywidth1 104 Web Login Password Current Health Popular Topics Photo Gallery Health Releases Archive A-Z Submit Releases Buy Health Create Pages Health line s Latest...
|
|
|
DOH warns of flu
CEBU CITY, Philippines - An official of the Department of Health in Central Visayas (DOH-7) advised the public to keep one's resistance high to avoid catching influenza or what is commonly known as flu.Susana Madarieta, DOH-7 regional...
|
|
|
The smaller the mozzie the nastier the bite
Experts have found that the smaller the mosquito the more likely that it is infected with viruses which cause human diseases.American entomologists have discovered that smaller-sized mosquitoes had more infections and more potential to...
|
|
|
Global Therapeutics Initiates Trial Of Next Generation Drug-Eluting Stent Using RNA Therapeutic Agent To Treat
BROOMFIELD, Colo.--(BUSINESS WIRE)--Global Therapeutics, a leading developer of innovative solutions for the cardiology market, today announced initiation of the world's first clinical trial of a drug eluting stent that uses an antisense RNA...
|
|
|
AVI BioPharma Announces Third Quarter 2008 Financial Results
AVI BioPharma, Inc.(NASDAQ: AVII), a developer of RNA-based drugs, today reported financial results for the three and nine months ending September 30, 2008. Revenues for the 2008 third quarter were $5.2 million, up from $2.9 million in...
|
|
|
AVI BioPharma Announces Third Quarter 2008 Financial Results
-- AVI BioPharma, Inc.(NasdaqGM:AVII - News), a developer of RNA-based drugs, today reported financial results for the three and nine months ending September 30, 2008. Revenues for the 2008 third quarter were $5.2 million, up from $2.9...
|
|
|
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
SAN DIEGO, Nov.6 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced that the Naval Medical Research Center (NMRC) plans to conduct preclinical and Phase 1 evaluation of a dengue DNA vaccine formulated with the...
|
|
|
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
SAN DIEGO, - Vical Incorporated (NASDAQ:VICL) today announced that the Naval Medical Research Center (NMRC) plans to conduct preclinical and Phase 1 evaluation of a dengue DNA vaccine formulated with the company's Vaxfectin(R) adjuvant and...
|
|
|
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin Adjuvant
/PRNewswire-FirstCall/ -- Vical Incorporated today announced that the Naval Medical Research Center (NMRC) plans to conduct preclinical and Phase 1 evaluation of a dengue DNA vaccine formulated with the company's Vaxfectin(R) adjuvant and...
|
|
|
Vical Commissioned for $1.3M to Produce Dengue Vaccine and Adjuvant for NMRCs Evaluation
GEN News Highlights GEN News Highlights Vicalreceived a $1.3 million contract from the Naval Medical Research Center (NMRC) to manufacture a dengue vaccine and adjuvant for testing.The NMRC will conduct preclinical and Phase I evaluations...
|
|
|
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin Adjuvant
/PRNewswire-FirstCall/ -- Vical Incorporated today announced that the Naval Medical Research Center (NMRC) plans to conduct preclinical and Phase 1 evaluation of a dengue DNA vaccine formulated with the company's Vaxfectin(R) adjuvant and...
|
|
|
Fight Obesity and Diabetes With the New 'Red Wine' Drug
(9 min ago) Islamic Militia Stone 13-year-old Girl to Death for adultery(14 min ago) Schizophrenics Lack Vital Brain Receptor(17 min ago) Doubling in Cancer Cases Predicted by 2050 Due to Rising Obesity Rates(31 min ago) Why the Dengue...
|
|
|
Doubling in Cancer Cases Predicted by 2050 Due to Rising Obesity Rates
Fight Obesity and Diabetes With the New 'Red Wine' Drug(7 min ago) Islamic Militia Stone 13-year-old Girl to Death for adultery(12 min ago) Schizophrenics Lack Vital Brain Receptor(15 min ago) (29 min ago) Why the Dengue Virus Prefers...
|
|
|
Study Discover Genetic Protein That Helps Detect Progress to Oesophageal Cancer
Fight Obesity and Diabetes With the New 'Red Wine' Drug(6 min ago) Islamic Militia Stone 13-year-old Girl to Death for adultery(11 min ago) Schizophrenics Lack Vital Brain Receptor(14 min ago) Doubling in Cancer Cases Predicted by 2050 Due...
|
|
|
Liver Transplant Patients Are at Risk of Developing Cancer
Fight Obesity and Diabetes With the New 'Red Wine' Drug(6 min ago) Islamic Militia Stone 13-year-old Girl to Death for adultery(11 min ago) Schizophrenics Lack Vital Brain Receptor(14 min ago) Doubling in Cancer Cases Predicted by 2050 Due...
|
|
|
The War on Dengue Fever
BANGKOK There was little that doctors could do for a 3-year-old boy brought to Bangkoks main childrens hospital two weeks ago with dengue fever.Like thousands before him, he had reached the most dangerous phase of the disease, dengue...
|
|
|
Flavivirus Therapy: Research reports on flavivirus therapy from H. Malet and colleagues provide new insights
Research reports on flavivirus therapy from H.Malet and colleagues provide new insights (NewsRx.com) -- New research, 'The flavivirus polymerase as a target for drug discovery,' is the subject of a report. According to a study from...
|
|
|
AVI BioPharma Announces Third Quarter 2008 Financial Results Conference Call
AVI BioPharma, Inc.(NASDAQ: AVII), a developer of RNA-based drugs, will hold a conference call to report third quarter 2008 financial results on Monday, November 10, 2008, at 9:30 a.m. Eastern time (6:30 a.m. Pacific time).
|
